The regulatory authorities of these two actors want to make it possible to immunize more people with a lower dose. The main objective is to avoid a possible shortage.
“This policy is not new for vaccines,” a WHO official told reporters in Geneva on Thursday. She called on Member States to relay their indications on the effectiveness of vaccines to improve the evaluation that the organization will carry out.
According to data released by the WHO also on Thursday, the number of new cases of monkeypox fell by 21% last week, to less than 6,000, and there are indications of a decline in Europe in particular. On the other hand, it has increased widely on the American continent where the majority of infections have now been observed.
A total of 12 people have died since early January from monkeypox. More than 41,000 cases have been identified in nearly 100 countries.
